2. HEALTH HOME Education ---University ---College ---School ---Tutorial ---Quiz ---Exam Research Press Wisdom Society Community Cohort Business ---Market ---Realty ---Rental Health cloud service
Health apps
The Cure Diseases Drugs Clinics Health alerts

Drug details

Zeposia (ozanimod capsules)

type of Sphingosine 1-Phosphate Receptor Modulators

Zeposia (ozanimod) is a sphingosine 1- phosphate receptor modulator used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing- remitting disease, and active secondary progressive disease, in adults.

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • nausea,
  • upper stomach pain,
  • loss of appetite,
  • dark urine,
  • rash,
  • vomiting,
  • fever,
  • lightheadedness,
  • shortness of breath,
  • tiredness,
  • yellowing of the skin or eyes (jaundice),
  • chest pain,
  • seizure,
  • severe headache,
  • blurred vision,
  • pounding in your neck or ears,
  • cough,
  • flu symptoms,
  • increased sensitivity to light,
  • slow heartbeats,
  • sudden confusion,
  • vision loss,
  • new or worsening shortness of breath,
  • feel like your heart is skipping beats,
  • seeing an unusual color in your vision,
  • blind spot or shadows in the center of your vision,
  • painful and frequent urination, and
  • neck stiffness
The following drugs are related to Zeposia, either as a replacement or used together:
  • Ampyra (dalfampridine extended-release tablets)
  • Aubagio (teriflunomide tablets)
  • Avonex (interferon beta-1a)
  • Azasan (azathioprine)
  • Imuran (azathioprine)
  • Lyvispah (baclofen oral granules)
  • Fleqsuvy (baclofen oral suspension)
  • Betaseron (interferon beta-1b)
  • Briumvi (ublituximab-xiiy injection)
  • Copaxone (glatiramer acetate)
  • Dxevo (dexamethasone tablets)
  • Tecfidera (dimethyl fumarate delayed release capsules)
  • Vumerity (diroximel fumarate delayed-release capsules)
  • Extavia (interferon beta-1b kit)
  • Gilenya (fingolimod capsules)
  • Glatopa (glatiramer acetate injection)
  • H.P. Acthar Gel (repository corticotropin injection)
  • Rebif (interferon beta-1a)
  • Kesimpta (ofatumumab injection)
  • Novantrone (mitoxantrone for injection concentrate)
  • Tysabri (natalizumab)
  • Ocrevus (ocrelizumab injection)
  • Plegridy (peginterferon beta-1a injection for subcutaneous use)
  • Prelone (prednisolone (syrup))
Back to List